Breaking News Instant updates and real-time market news.

ARRY

Array BioPharma

$17.10

0.07 (0.41%)

08:04
07/13/18
07/13
08:04
07/13/18
08:04

Array BioPharma: NCCN recommends BRAFTOVI, MEKTOVI combination

Array BioPharma announced that the National Comprehensive Cancer Network has updated the Clinical Practice Guidelines in Oncology for Melanoma to include BRAFTOVI in combination with MEKTOVI as a Category 1 first-line and second-line treatment option for patients with BRAFV600E or BRAFV600K-mutant metastatic or unresectable melanoma.

  • 16

    Jul

  • 17

    Jul

ARRY Array BioPharma
$17.10

0.07 (0.41%)

06/20/18
CANT
06/20/18
NO CHANGE
Target $24
CANT
Overweight
Array BioPharma shares could have more room to advance, says Cantor Fitzgerald
Cantor Fitzgerald analyst Mara Goldstein believes Array BioPharma's combination of binimetinib/encorafenib has the "potential to be best-in-class and take a market-leader position." The FDA action date is June 30. Further, the analyst sees opportunity in BRAF+ CRC based on the safety lead-in portion of the Beacon study, which she believes could expand the potential market, with updated results to be presented on June 23. Goldstein thinks Array shares "could have further room to advance" and keeps an Overweight rating on the name with a $24 price target.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $21
PIPR
Overweight
Piper backs Overweight on Array BioPharma after 'impressive' BEACON update
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $21 price target on Array BioPharma after the company reported an "impressive" one-year overall survival rate of 62% from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAFV600E-mutant metastatic colorectal cancer. In a research note to investors, Tenthoff also said he is confident in the approval of Braftovi + Mektovi in BRAF-mutant melanoma by the June 30 PDUFA date.
06/25/18
RHCO
06/25/18
NO CHANGE
Target $25
RHCO
Buy
Array BioPharma price target raised to $25 from $19 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Array BioPharma to $25 after the company's updated data from the lead in portion of the Phase 3 BEACON CRC trial of bini/enco/cetuximab. Lawson notes that Array offered survival data for the first time, and that the 12-month OS was "far better" than with SOC regimens at less than 6 months. The analyst believes the findings are "encouraging", increasing his probability of success and market penetration estimates for BEACON CRC while keeping his Buy rating on Array BioPharma.
06/27/18
PIPR
06/27/18
NO CHANGE
Target $25
PIPR
Overweight
Piper ups Array BioPharma price target to $25 after early BRAF-melanoma approval
Piper Jaffray analyst Edward Tenthoff said he is encouraged by the early approval of Array Biopharma's Braftovi and Mektovi combination in BRAF-mutant melanoma ahead of the June 30 PDUFA date and he believes the label "looks good." Tenthoff, who thinks the improved tolerability and "best in class" efficacy of the combination will support rapid uptake, raised his price target on Array shares to $25 from $21 following the approval announcement and he keeps an Overweight rating on the stock.

TODAY'S FREE FLY STORIES

MSFT

Microsoft

$107.60

-1.94 (-1.77%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Microsoft co-founder Paul Allen dead at 65 »

Vulcan Inc. released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

OII

Oceaneering

$25.69

0.4 (1.58%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Oceaneering provides update following Hurricane Michael »

Oceaneering International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

JOE

Saint Joe Co.

$15.28

0.01 (0.07%)

18:07
10/15/18
10/15
18:07
10/15/18
18:07
Hot Stocks
Saint Joe released additional information regarding Hurricane Michael »

The St. Joe Company …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.41

0.055 (0.36%)

18:05
10/15/18
10/15
18:05
10/15/18
18:05
Periodicals
Petrobras anticipates reviving TAG sale over next month, Reuters says »

Petrobras expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Hot Stocks
Adobe says it sees increased demand for PDF capabilities »

Says it has over 300,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

, GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Periodicals
Google's Greene will not attend Saudi Aarabia summit, Bloomberg says »

Diane Greene, who runs…

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

CE

Celanese

$97.99

-0.685 (-0.69%)

18:01
10/15/18
10/15
18:01
10/15/18
18:01
Hot Stocks
Celanese unveils Customer Options Mapping approach to customer engagement »

Celanese announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

OPGN

OpGen

$1.91

-0.01 (-0.52%)

17:57
10/15/18
10/15
17:57
10/15/18
17:57
Hot Stocks
OpGen selected to participate in AMR surveillance initiative during Q3 »

OpGen continues to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPGN

OpGen

$1.91

-0.01 (-0.52%)

17:45
10/15/18
10/15
17:45
10/15/18
17:45
Earnings
OpGen says preliminary Q3 revenue $550K vs. $750K in Q317 »

Total preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPX

Tempur Sealy

$47.87

0.03 (0.06%)

, SHLD

Sears

$0.31

-0.0901 (-22.52%)

17:44
10/15/18
10/15
17:44
10/15/18
17:44
Hot Stocks
Tempur Sealy: Sears represented less than 5% of company's global net sales »

In connection with the…

TPX

Tempur Sealy

$47.87

0.03 (0.06%)

SHLD

Sears

$0.31

-0.0901 (-22.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$115.95

0.71 (0.62%)

17:42
10/15/18
10/15
17:42
10/15/18
17:42
Hot Stocks
SPDR Gold Trust rise to 748.76MT from 744.64MT »

This is the 2nd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGC

India Globalization Capital

$5.30

0.35 (7.07%)

17:35
10/15/18
10/15
17:35
10/15/18
17:35
Syndicate
Breaking Syndicate news story on India Globalization Capital »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RWLK

ReWalk Robotics

$0.81

-0.0038 (-0.47%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Syndicate
Breaking Syndicate news story on ReWalk Robotics »

ReWalk Robotics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$123.59

0.12 (0.10%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Initiation
Zimmer Biomet initiated  »

Zimmer Biomet initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 26

    Oct

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Rio Tinto »

Rio Tinto sees Pilbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$249.10

0.64 (0.26%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Teleflex initiated  »

Teleflex initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Hot Stocks
Rio Tinto reports Q3 Pilbara iron ore output 82.5M tons, down 3% from last year »

Pilbara iron ore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYK

Stryker

$169.42

-1.66 (-0.97%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Stryker initiated  »

Stryker initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MDT

Medtronic

$93.81

-0.85 (-0.90%)

17:32
10/15/18
10/15
17:32
10/15/18
17:32
Initiation
Medtronic initiated  »

Medtronic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

17:31
10/15/18
10/15
17:31
10/15/18
17:31
Hot Stocks
Adobe says it is expanding creative cloud to non-professionals »

Says over the last few…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRC

Hill-Rom

$87.26

-1.04 (-1.18%)

17:30
10/15/18
10/15
17:30
10/15/18
17:30
Initiation
Hill-Rom initiated  »

Hill-Rom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

EW

Edwards Lifesciences

$141.95

-1.44 (-1.00%)

17:29
10/15/18
10/15
17:29
10/15/18
17:29
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CNMD

CONMED

$73.17

0.73 (1.01%)

17:28
10/15/18
10/15
17:28
10/15/18
17:28
Initiation
CONMED initiated  »

CONMED initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

17:27
10/15/18
10/15
17:27
10/15/18
17:27
Syndicate
Breaking Syndicate news story on T2 Biosystems »

T2 Biosystems files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.43

-0.56 (-1.51%)

17:26
10/15/18
10/15
17:26
10/15/18
17:26
Initiation
Boston Scientific initiated  »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.